Skip to main content
Top-Rated Stocks  
NASDAQ:KRTX

Karuna Therapeutics Insider Trades

$115.55
+0.37 (+0.32 %)
(As of 05/12/2021 03:59 PM ET)
Add
Compare
Today's Range
$113.54
▼
$120.00
50-Day Range
$107.45
▼
$122.93
52-Week Range
$69.58
▼
$146.97
Volume7,423 shs
Average Volume191,977 shs
Market Capitalization$3.40 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.07

Insider Trades

Karuna Therapeutics (NASDAQ:KRTX) Insider Buying and Selling Activity

Insider Ownership Percentage: 18.10%
Insider Buying (Last 12 Months): $62,118.00
Insider Selling (Last 12 Months): $317,072,179.63

Insider Buying and Selling by Quarter


Karuna Therapeutics (NASDAQ KRTX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2021Atul PandeDirectorSell2,500$110.61$276,525.002,500  
4/12/2021Andrew Craig MillerCOOSell5,000$114.22$571,100.0050,500  
4/1/2021Atul PandeDirectorSell2,500$120.01$300,025.002,500  
3/10/2021Andrew Craig MillerCOOSell5,000$118.48$592,400.0050,500  
2/9/2021Puretech Health LlcMajor ShareholderSell1,000,000$118.00$118,000,000.002,406,564  
2/1/2021Atul PandeDirectorSell2,500$100.00$250,000.002,500  
1/11/2021Andrew Craig MillerCOOSell5,000$105.11$525,550.0049,072  
1/8/2021Troy A IgnelziCFOSell8,000$104.49$835,920.0021,000  
12/14/2020Atul PandeDirectorSell5,714$92.64$529,344.965,714  
12/10/2020Andrew Craig MillerCOOSell5,000$94.82$474,100.0045,500  
11/12/2020Andrew Craig MillerCOOSell30,000$101.69$3,050,700.00
11/12/2020Atul PandeDirectorSell5,000$96.84$484,200.00
11/9/2020Troy A IgnelziCFOSell9,318$105.48$982,862.645,564  
11/6/2020Troy A IgnelziCFOSell564$108.15$60,996.605,564  
11/3/2020Atul PandeDirectorSell5,000$85.00$425,000.005,000  
10/12/2020Andrew Craig MillerCOOSell5,000$78.67$393,350.0038,000  
9/16/2020Atul PandeDirectorSell5,000$85.00$425,000.005,000  
9/10/2020Andrew Craig MillerCOOSell5,000$75.52$377,600.0038,000  
9/8/2020James HealyDirectorBuy504$73.00$36,792.00  
9/8/2020Troy A IgnelziCFOSell2,000$73.30$146,600.007,000  
9/4/2020Heather PrestonDirectorBuy350$72.36$25,326.005,800  
8/26/2020Puretech Health LlcMajor ShareholderSell1,333,333$76.21$101,613,307.933,406,564  
7/13/2020Atul PandeDirectorSell5,000$95.43$477,150.005,000  
7/8/2020Troy A IgnelziCFOSell8,000$98.74$789,920.006,000  
7/1/2020Stephen K BrannanInsiderSell7,728$108.53$838,719.8415,000  
6/29/2020Steven M PaulCEOSell292,207$103.50$30,243,424.50  
6/16/2020Andrew Craig MillerCOOSell25,000$94.41$2,360,250.0033,000  
6/15/2020Troy A IgnelziCFOSell6,000$89.75$538,500.002,000  
6/12/2020Andrew Craig MillerCOOSell8,333$93.28$777,302.2433,000  
6/12/2020Edmund HarriganDirectorSell30,000$91.79$2,753,700.0075,163  
6/1/2020Andrew Craig MillerCOOSell25,000$90.64$2,266,000.0025,000  
6/1/2020Stephen K BrannanInsiderSell7,728$90.64$700,465.9212,500  
5/22/2020Puretech Health LlcMajor ShareholderSell555,500$81.03$45,012,165.004,745,397  
5/8/2020Troy A IgnelziCFOSell7,500$83.38$625,350.007,500  
5/1/2020Andrew Craig MillerCOOSell25,000$76.98$1,924,500.0025,000  
5/1/2020Stephen K BrannanInsiderSell7,728$79.38$613,448.6410,000  
4/1/2020Andrew Craig MillerCOOSell25,000$64.37$1,609,250.0010,654  
4/1/2020Stephen K BrannanInsiderSell7,728$67.36$520,558.087,500  
3/12/2020Heather PrestonDirectorBuy2,050$71.71$147,005.503,400  
3/10/2020Heather PrestonDirectorBuy1,000$80.00$80,000.003,400  
1/22/2020Puretech Health LlcMajor ShareholderSell2,100,000$95.67$200,907,000.005,295,397  
1/9/2020Heather PrestonDirectorBuy788$70.50$55,554.002,400  
1/3/2020Heather PrestonDirectorBuy1,427$69.80$99,604.60474  
11/25/2019James HealyDirectorBuy156,250$96.00$15,000,000.00  
7/2/2019Arch Venture Partners Ix, LlcMajor ShareholderBuy200,000$16.00$3,200,000.00  
7/2/2019James HealyDirectorBuy700,000$16.00$11,200,000.00  
6/28/2019Steven M PaulCEOBuy10,000$23.04$230,400.00  
(Data available from 1/1/2013 forward)
This page was last updated on 5/12/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.